Standout Papers

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer ... 2017 2026 2020 2023 1.1k
  1. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy (2017)
    George W. Sledge, Masakazu Toi et al. Journal of Clinical Oncology
  2. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer (2017)
    Matthew P. Goetz, Masakazu Toi et al. Journal of Clinical Oncology

Immediate Impact

1 from Science/Nature 64 standout
Sub-graph 1 of 18

Citing Papers

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
13 intermediate papers

Works of Nawel Bourayou being referenced

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
2017 Standout
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Nawel Bourayou 2026 1797 5 723 23 2.3k
Olga Burdaeva 1630 1563 3 621 27 2.0k
Kathy Puyana Theall 2049 1828 4 787 26 2.3k
Meena Okera 1678 1488 2 617 32 2.0k
Han Koh 1883 2178 6 836 25 2.7k
Ravindranath Patel 1462 1374 8 575 14 1.8k
Susana Barriga 3179 2770 4 1194 25 3.5k
C. Giorgetti 2144 2077 11 874 33 2.9k
Katalin Boér 1840 1650 12 644 52 2.5k
S. Phan 1340 1604 6 513 43 2.4k
Eric Gauthier 2492 2337 9 889 41 3.0k

All Works

Loading papers...

Rankless by CCL
2026